Novel ImmTAV molecules for the treatment of HBV

T Laftsoglou, Bent K. Jakobsen(Mission Therapeutics (United Kingdom)), Natalia Chepisiuk, Ajay Narayan Verma, N Liddy, Tianna Grant(University of California, San Francisco), Jürg W. Müller, C Perot, Annelise Vuidepot(Immunocore (United Kingdom)), S Paston, D Sant, Jianting Long(Sun Yat-sen University), Cara C. Burns(Centers for Disease Control and Prevention), M Dembek, A. Knox, J Donoso, Andreas Walker, M Vranas, Emma Gostick(University Hospital of Wales), Pratibha Singh, Lucy Dorrell(MRC Human Immunology Unit), Darren B. Leneghan(Immunocore (United Kingdom)), Mary Karin Connolly, Bum-Ryoul Choi, Ruth Suckling, Simon Léonard, G Stahlberg, Márcia Regina Pereira Monteiro, Zoë Wallace(Immunocore (United Kingdom)), Wilawan Bunjobpol(National Cancer Centre Singapore), Karl‐Heinz Wiederhold, Sara Crespillo, L Godinho, Frank Seifert(Universitätsklinikum Erlangen), P. J. Molloy, N HASSAN(Damanhour University), Cheryl Barber, S. S. Cook, D. Kay, C Pirson, Ruth Martinez-Hague, J Brener

Journal of Viral Hepatitis

January 1, 2018

Cited by 1

Related Papers

Characterization of a Novel Coronavirus Associated with Severe Acute Respiratory Syndrome

|Science|2003|2.6k

A human memory T cell subset with stem cell–like properties

|Nature Medicine|2011|2k

PD-1 is a regulator of virus-specific CD8+ T cell survival in HIV infection

|The Journal of Experimental Medicine|2006|880

Immunization with vaccinia virus induces polyfunctional and phenotypically distinctive CD8+ T cell responses

|The Journal of Experimental Medicine|2007|490

Plug-and-Display: decoration of Virus-Like Particles via isopeptide bonds for modular immunization

|Scientific Reports|2016|438